• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • Instagram
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • What is ALS/MND
  • Find a Member Association
  • Support for PALS & CALS
    • Advocacy
      • Fundamental Rights of People with ALS/MND and Caregivers
      • Advocacy Toolkit
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
      • Open Label Extension
      • Expanded Access
    • Care Services
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
    • Drugs in Clinical Trial
      • Amylyx – AMX0035
      • Biogen – Tofersen
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Orphazyme – Arimoclomol
      • T Regulatory Cell Therapies
    • Approved Drugs
      • Riluzole/Tiglutik
      • Radicava/Edaravone
      • Neudexta
  • Events/Programs
    • Calendar of Events/Programs
    • Alliance Webinars
    • Alliance Meeting
    • Allied Professionals Forum
    • ALS/MND Connect
    • Global Day
    • March of Faces
    • International Symposium on ALS/MND
  • About
    • Who We Are
    • Board of Directors
    • Committees/Advisory Councils
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Innovation and Technology Council
      • Governance Committee
      • Budget and Finance Committee
    • Staff
    • History
    • Archives
      • Newsletters
      • Meetings
    • Awards
  • Members
    • Member Registration
    • Forgot Password

Asociación Colombiana de Esclerosis Lateral Amiotrófica

(ACELA)
Colombia
Date founded: 28 May 2008
Region covered:

Colombia


Address:

Carrera 66 # 79 A – 82
Apt 3-102
Bogotá, Colombia


Asociación Colombiana de Esclerosis Lateral Amiotrófica Activities

The main purpose of the organization is to advise patients, family members and caregivers, to deal with the disease Amyotrophic Lateral Sclerosis ALS so that they have the best possible quality of life for the patient and those who are around him or her. To achieve its goals, the organization will perform following specific activities:

  • To organize Medical and practical seminars for patients, family members of patients and caregivers
  • To coordinate activities with medical organizations and ALS research institutes
  • To promote the appropriate and dignified medical care for ALS patients
  • To raise donations for the progression of the Association
  • To establish and maintain relationships with International ALS Associations and with national and foreign organizations with similar purposes
  • To promote the creation of ALS chapters in other cities
  • To advise patients and family members regarding the health rights and related Constitutional rights
  • To find psychological support for patients and family members
  • To make the society sensitive about the devastating effects of the disease. to request and to obtain from the central government and the local governments all the required support to find solutions
  • To publish manuals, texts and magazines that contribute to spread the results of the activities performed by ACELA and other activities with similar purposes and to promote meetings, seminars, courses, academic events and every media of exchange of ideas for the best spread of the purposes and achievements of the Association
  • To promote only medicaments approved by the medical science and that have demonstrated beneficial evidence for the ALS patients considering the ethical principles: Respect for the Persons, benefits and justice

Asociación Colombiana de Esclerosis Lateral Amiotrófica Branches/Chapters

6

Contacts

  • Orlando Ruiz, Founder

Phone:

+57 1 7358360, +57 320 962 1211

Email:

presidencia@acelaweb.org

Website:

www.acelaweb.org

Facebook:

www.facebook.com/acelacolombia

Twitter:

twitter.com/ColombiaELA

Primary Sidebar

Back to all

Subscribe to our Bi-Monthly Newsletter

Fill out the form below to subscribe to the Alliance’s bi-monthly newsletter, packed with updates from members associations from around the world!

Footer

Keep in touch

Sign up to receive updates and to hear what's going on in the International Alliance of ALS/MND Associations.

"*" indicates required fields

 
This field is for validation purposes and should be left unchanged.

  • Email
  • Facebook
  • Instagram
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2022 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login